Biopharmaceuticals are an increasingly important tool in the treatment of disease. Comprising nearly half of the leading pharmaceutical products, biologics represent one of the largest growth drivers in the industry. However, it is also one of the most highly regulated and complex industries. For many companies, understanding the competitive landscape can be a difficult task. With the launch of the first wave of biosimilars, this task has only become more difficult. For other companies, entering into the biopharmaceutical industry can be daunting consideration. TCI has worked with many biopharmaceutical and pharmaceutical companies to help simplify the complex environment and to gain a competitive advantage.